Clinical Trials Logo

Clinical Trial Summary

Currently, the gold standard to obtain bioavailable testosterone results is radioimmunoassay (RIA). However, this assay requires specific equipment. Giton in 2006 proposed an optimized calculation of the Vermeulen equation, the results of which seem to be well correlated with those obtained by RIA. The aim of this study is to determine if the bioavailable testosterone levels determined by both methods are similar in order to replace the usual RIA assay of bioavailable testosterone by this calculation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04807231
Study type Observational
Source Centre Hospitalier Universitaire, Amiens
Contact Marion SOYEZ, DR
Phone 03 22 08 71 02
Email Soyez.Marion@chu-amiens.fr
Status Recruiting
Phase
Start date March 11, 2021
Completion date March 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05487794 - Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men With Erythrocytosis N/A
Not yet recruiting NCT02600650 - EndogenousTestosterone Response to a Testosterone Boosting Supplement N/A
Completed NCT03210558 - Study of Testosterone and Athlete Response Phase 2
Completed NCT05448378 - Evaluation of D-chiro-inositol Treatments N/A
Completed NCT02799277 - A Multinomial Process Model of Moral Judgment Phase 4
Withdrawn NCT04298840 - Influence of Creatine Monohydrate Supplementation on Androgens and Global Hair Assessments N/A
Active, not recruiting NCT02134470 - Diagnostic Relevance of Salivary Testosterone Concentrations in Doping Control. N/A
Completed NCT02434562 - Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation N/A